Fraud in scientific research: The prosecutor's approach
Accountability in ResearchPublished 1 January 1992
Breckinridge L. Willcox
Citations25
SJR quartileQ1
SJR score0.64
SNIP1.43
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
(1992). Fraud in scientific research: The prosecutor's approach. Accountability in Research: Vol. 2, No. 2, pp. 139-151.
Keywords
Social Sciences
New England Journal of MedicineMisrepresentation and Responsibility in Medical Research
143 Citations1987Robert L. Engler, James W. Covell +3 more
The analysis of this case leads to the conclusion that research fraud, although probably rare, in view of the size of the research establishment, may evade detection, and that there are scientists prepared to run the appreciable risk of submitting inaccurate statements for publication.
New England Journal of MedicineScientific Misconduct in Investigations Drug Trials
53 Citations1985Martin F. Shapiro, Robert P. Charrow
JAMAThe Role of Data Audits in Detecting Scientific Misconduct
50 Citations1989Martin F. Shapiro
There was no evidence of a decline over time in the rate of detection of many categories of deficiencies, and some investigators were able to continue to participate in drug trials after flagrant violations of recognized norms of research.
New England Journal of MedicineFraud in Biomedical Research
42 Citations1988Marcia Angell, Arnold S. Relman
Hearings to investigate the extent of fraud in biomedical research and the response of the scientific community to it suggested that the biomedical-research enterprise requires some sort of policing by the government and that researchers thought guilty should be thought guilty.
JAMAEditors and Auditors
38 Citations1989Drummond Rennie
A 16-year-old girl who had had seizures since birth, but who, while receiving antiepileptic drugs that included Mysoline and Clonopin, had a seizure frequency of one or two per week is described.
JAMAThe Role of Data Audits in Detecting Scientific Misconduct-Reply
14 Citations1990Robert P. Charrow
Dr Heersink insists that, when audits have raised serious questions about misconduct in investigational drug research, the physician should be "presumed innocent until proved guilty" and "should not be stripped of his or her livelihood and reputation" by arbitrary bureaucratic judgment.
JAMAThe Role of Data Audits in Detecting Scientific Misconduct
1 Citations1990John P. Conomy
To say that the patient went on, with a nongeneric drug, to have seizures at some further point in time neither addresses nor excuses the inadequacy of bioavailabilty of potentially protective pharmacologic agents at the time the patient was studied.